Transcaval retrograde transcatheter aortic valve replacement for patients with no other access: First-in-man experience with corevalve

JACC: Cardiovascular Interventions

Volumn 7, Issue 9, 2014, Pages 1075-1077

  Martinez Clark, Pedro O ^a   Singh, Vikas ^a   Cadena, Jairo A ^a   Cucalon Reyes, Angela Maria ^a   Gallegos, Cesia ^a   Dager, Antonio ^a   Greenbaum, Adam ^a   O'Neill, William W ^a  

^a Interventional Concepts Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN;

AGED; ANTICOAGULATION; AORTA STENOSIS; AORTOGRAPHY; ARTIFICIAL HEART PACEMAKER; BLOOD CLOTTING TIME; CARDIAC SURGEON; CARDIOVASCULAR MORTALITY; CASE REPORT; ELECTROSURGERY; FEMALE; FEMORAL ARTERY; FOLLOW UP; GENERAL ANESTHESIA; HOSPITAL READMISSION; HUMAN; INFERIOR CAVA VEIN; INTRAVASCULAR CATHETER; LETTER; MALE; PERCUTANEOUS AORTIC VALVE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; TRANSCATHETER AORTIC VALVE IMPLANTATION; VASCULAR ACCESS; VASCULAR CLOSURE DEVICE; VERY ELDERLY; AORTA; AORTA VALVE; AORTIC VALVE STENOSIS; DEVICES; HEART CATHETERIZATION; HEART VALVE PROSTHESIS; HEART VALVE REPLACEMENT; PATHOPHYSIOLOGY; PHLEBOGRAPHY; PROCEDURES; PROSTHESIS; RADIOGRAPHY; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; AORTA; AORTIC VALVE; AORTIC VALVE STENOSIS; AORTOGRAPHY; CARDIAC CATHETERIZATION; FEMALE; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MALE; PHLEBOGRAPHY; PROSTHESIS DESIGN; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; VENA CAVA, INFERIOR;

EID: 84908212327     PISSN: 19368798     EISSN: 18767605     Source Type: Journal    
DOI: 10.1016/j.jcin.2014.03.008     Document Type: Letter

References (6)

1. M. Gilard, H. Eltchaninoff, and B. Iung Registry of transcatheter aortic-valve implantation in high-risk patients N Engl J Med 366 2012 1705 1715
2. H. Jilaihawi, R. Bonan, and A. Asgar Anatomic suitability for present and next generation transcatheter aortic valve prostheses: evidence for a complementary multidevice approach to treatment J Am Coll Cardiol Intv 3 2010 859 866
3. Popma JJ, CoreValve US Clinical Investigators. CoreValve US Pivotal Trial Extreme Risk Iliofemoral study results. Presented at: TCT2013; November 28, 2013; San Francisco, CA.
4. A.P. Kappetein, S.J. Head, and P. Généreux Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document J Am Coll Cardiol 60 2012 1438 1454
5. M. Halabi, K. Ratnayaka, A.Z. Faranesh, M.Y. Chen, W.H. Schenke, and R.J. Lederman Aortic access from the vena cava for large caliber transcatheter cardiovascular interventions: pre-clinical validation J Am Coll Cardiol 61 2013 1745 1746
6. A.B. Greenbaum, W.W. O'Neill, and G. Paone Caval-aortic access to allow transcatheter aortic valve replacement in otherwise ineligible patients: initial human experience J Am Coll Cardiol 63 2014 2795 2804